Joana Goncalves, M.D.

Joana Goncalves, M.D.

former Chief Medical OfficeratTvardi Therapeutics· In proxies 2022–2023

Pay in FY2023-18% from the year before · Tvardi Therapeutics stock -93.1% the same year

Joana Goncalves, M.D. was paid $1.3M in FY2023 (Dec), down 18%. Tvardi Therapeutics stock fell 93.1% that year.

Pay$100 in the stock at the end of FY21 → $6
Pay is from the Summary Compensation Table of each Tvardi Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tvardi TherapeuticsPublic company · 4 yr
    • former Chief Medical Officer2022 – Present · 4 yrStock in role -100%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?